Skip to content

Probiotic review found inconsistent evidence for schizophrenia and depression symptoms

A trial review found no significant difference in schizophrenia symptom-score reductions, while another pooled result was significant but insufficiently described in the abstract.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

The review did not find consistent evidence that probiotics improve depression or schizophrenia. Schizophrenia symptom-score reductions did not differ significantly from placebo. Another pooled comparison reached statistical significance, but the abstract does not identify its outcome or report its effect size. That mixed reporting cannot establish a dependable psychiatric benefit.

Keep in mind

This abstract-based account cannot resolve the unspecified pooled result. Considerable variation across trials and missing details on probiotic preparations, follow-up and outcome-specific estimates limit interpretation. The nonsignificant schizophrenia comparison does not prove that probiotics have no effect.

THE NUMBERS, WITH CONTEXT

What researchers found

P = .546

Schizophrenia symptom-score reduction (PANSS)

Probiotics versus placebo; the reduction did not differ significantly. Assessment timing was not reported.

Nutr Health, 2026 · Original source ↓

The outcome needs to be identifiable

The authors combined randomized trials involving different psychiatric diagnoses and examined variation between studies. A result for schizophrenia symptom scores should not be treated as an answer about depression, especially when the other pooled outcome is left unspecified.

Subgroups remain questions

Subgroup results varied by geographic region and ethnicity, and vitamin D status was flagged for further study. The abstract does not establish a subgroup or supplement combination with a reliable advantage.

CHECK THE ORIGINAL

The original publication

Evaluating the efficacy of probiotics in schizophrenia and depression: A meta-analysis of clinical outcomes and subgroup effects.

Tai XY, Tee SF, Tang PY
Nutr Health · 2026

PubMed ID
41259365
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.